A detailed history of Aster Capital Management (Difc) LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 23,862 shares of CDNA stock, worth $305,194. This represents 0.1% of its overall portfolio holdings.

Number of Shares
23,862
Previous 318 7403.77%
Holding current value
$305,194
Previous $6.81 Million 7663.56%
% of portfolio
0.1%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$17.64 - $25.07 $415,316 - $590,248
23,544 Added 7403.77%
23,862 $529 Million
Q4 2024

Feb 13, 2025

BUY
$20.4 - $32.2 $6,487 - $10,239
318 New
318 $6.81 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $684M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Aster Capital Management (Difc) LTD Portfolio

Follow Aster Capital Management (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aster Capital Management (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aster Capital Management (Difc) LTD with notifications on news.